South Texas Money Management’s AbbVie ABBV Stock Holding History

South Texas Money Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$224K	Buy	+2,956	New	+$203K	0.01%	364
2019 Q2	–	Sell	-4,920	Closed	-$397K	–	209
2019 Q1	$397K	Sell	4,920 -1,717	-26%	-$140K	0.02%	158
2018 Q4	$612K	Sell	6,637 -2,800	-30%	-$246K	0.03%	138
2018 Q3	$893K	Sell	9,437 -7,194	-43%	-$682K	0.04%	128
2018 Q2	$1.54M	Buy	16,631 +41	+0.2%	+$4K	0.07%	104
2018 Q1	$1.57M	Buy	16,590 +2,710	+20%	+$298K	0.07%	102
2017 Q4	$1.34M	Sell	13,880 -10,773	-44%	-$1.02M	0.06%	98
2017 Q3	$2.19M	Buy	24,653 +1,531	+7%	+$117K	0.1%	75
2017 Q2	$1.68M	Buy	23,122 +1,278	+6%	+$85.9K	0.08%	85
2017 Q1	$1.42M	Sell	21,844 -519	-2%	-$32.6K	0.07%	94
2016 Q4	$1.4M	Buy	22,363 +771	+4%	+$47.1K	0.07%	90
2016 Q3	$1.36M	Sell	21,592 -733	-3%	-$47.5K	0.08%	91
2016 Q2	$1.38M	Sell	22,325 -310	-1%	-$18.9K	0.08%	86
2016 Q1	$1.29M	Buy	22,635 +701	+3%	+$39.1K	0.07%	91
2015 Q4	$1.3M	Sell	21,934 -981	-4%	-$56.5K	0.07%	94
2015 Q3	$1.25M	Sell	22,915 -1,979	-8%	-$129K	0.08%	92
2015 Q2	$1.67M	Sell	24,894 -862	-3%	-$56.3K	0.1%	81
2015 Q1	$1.51M	Sell	25,756 -2,402	-9%	-$145K	0.09%	77
2014 Q4	$1.84M	Sell	28,158 -2,487	-8%	-$157K	0.11%	75
2014 Q3	$1.77M	Buy	30,645 +8,189	+36%	+$455K	0.11%	71
2014 Q2	$1.27M	Buy	22,456 +2,136	+11%	+$112K	0.08%	80
2014 Q1	$1.04M	Sell	20,320 -68	-0.3%	-$3.44K	0.07%	80
2013 Q4	$1.08M	Buy	20,388 +136	+0.7%	+$6.68K	0.08%	85
2013 Q3	$906K	Buy	20,252 +196	+1%	+$8.69K	0.07%	84
2013 Q2	$829K	Buy	+20,056	New	+$877K	0.07%	86

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

South Texas Money Management's ABBV Position: Q3 2019 in Review

South Texas Money Management opened a new position in AbbVie (ABBV) in Q3 2019: 2,956 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #364 among its holdings. This is a return to the name: South Texas Money Management previously reported a position in ABBV as recently as Q1 2019.

South Texas Money Management first reported a position in ABBV in Q2 2013 and has held it in 25 quarters since. The position peaked at $2.19M in Q3 2017. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

South Texas Money Management held 2,956 shares of AbbVie worth $224K as of Q3 2019.
AbbVie was a new South Texas Money Management position in Q3 2019.
AbbVie made up 0.01% of South Texas Money Management's portfolio in Q3 2019, its #364 holding.
South Texas Money Management first reported a position in AbbVie in Q2 2013 and has held it in 25 quarters since.
South Texas Money Management's AbbVie position peaked at $2.19M in Q3 2017.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on South Texas Money Management's 13F filing for Q3 2019, filed 13 Nov 2019.